Develops brain electrodes for epilepsy and Parkinson's disease.
Jun 2026Revenue $9.47M/yrExpenses $17.4M/yr
No trendCash runway ≈ 3 months from Jun 2026
Figures by year
When will NEUROONE MEDICAL TECHNOLOGIES be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $9.47M and expenses $17.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Sep 2025 | $9.10M | $13.3M | −$4.23M |
| Sep 2024 | $3.45M | $15.3M | −$11.9M |
| Sep 2023 | $1.95M | $13.9M | −$12.0M |
| Sep 2022 | $171K | $10.2M | −$10.0M |
| Sep 2021 | $178K | $10.4M | −$10.2M |
| Dec 2016 | $0.00 | $32.6K | −$32.6K |
| Dec 2015 | $0.00 | $30.9K | −$30.9K |
| Dec 2014 | $773 | $36.7K | −$35.9K |
| Dec 2013 | $1.25K | $26.3K | −$25.1K |
| Dec 2012 | $921 | $14.7K | −$13.7K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.